{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:59:07Z","timestamp":1794751147734,"version":"4.9.1"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p><jats:bold>Summary<\/jats:bold> Missense mutations are not considered a common cause of type 3 von Willebrand\u2019s disease (VWD), the most severe defect of von Willebrand factor (VWF) characterized by undetectable levels of this protein in plasma and platelets. Nevertheless, several missense mutations have been identified in these patients. In this study, we report the cases of two Italian patients with type 3 VWD, both compound heterozygotes for different missense mutations and null alleles, p.D141Y\/c.2016_2019del and p.C275S\/p.W222X. We performed <jats:italic>in vitro<\/jats:italic> expression studies of the candidate missense mutations, both located in the D1 domain of VWF propeptide, to confirm their link with the disease and to understand the mechanisms of type 3 VWD responsible in these patients. Mutant and wild\u2010type (WT) expression vectors were used for transient transfection and co\u2010transfection studies in COS\u20107 cells. Single construct transfections of both missense mutations showed a strongly reduced but detectable secretion of recombinant (r)VWFs (approximately 15% of WT), with essentially only dimers being visualized on multimeric analysis. As expected, expression of a single construct of either mutation with the WT, showed mildly reduced secretion (approximately 40% of WT) and a full set of multimers. These expression studies indicate that the two amino acids D141 and C275 are key residues in the tertiary structure of the VWF propeptide. Their replacement with a tyrosine and a serine, respectively, might compromise propeptide folding, affecting both its intracellular survival and its capacity to mediate multimerization. Co\u2010expression of hybrid rVWFs confirmed the recessive inheritance pattern of these missense mutations.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01682.x","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T07:37:51Z","timestamp":1204616271000},"page":"549-555","source":"Crossref","is-referenced-by-count":21,"title":["Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease"],"prefix":"10.1111","volume":"14","author":[{"given":"L.","family":"BARONCIANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"FEDERICI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"COZZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"LA MARCA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"PUNZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"RUBINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"CANCIANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"MANNUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0133"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)47144-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00359a014"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002654200"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02591.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90648-I"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V96.5.1808","article-title":"Von Willebrand factor storage and multimerization: 2 independent intracellular processes","volume":"96","author":"Haberichter SL","year":"2003","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler JE","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-9796(03)00033-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02349.x"},{"key":"e_1_2_6_12_2","first-page":"283","article-title":"Mutational analysis of the von Willebrand factor gene in 27 families from Turkey with von Willebrand disease","volume":"82","author":"Abuzenadah AM","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1241"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.560"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00206958"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01847.x"},{"key":"e_1_2_6_17_2","first-page":"77","article-title":"A sensitive ristocetin co\u2010factor activity assay with recombinant glycoprotein Ib\u03b1 for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici AB","year":"2004","journal-title":"Haematology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90129-Z"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.4.796.796"},{"key":"e_1_2_6_20_2","author":"Sambrook J","year":"1989","journal-title":"Molecular Cloning: A Laboratory Manual"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614063"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V83.6.1542.1542","article-title":"Leu 697\u2010>Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease","volume":"83","author":"Hilbert L","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.6.1140.1140"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V74.7.2433.2433","article-title":"Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygosites for severe von Willebrand disease","volume":"74","author":"Mannucci PM","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00399a013"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1882"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0789"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb08176.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2281"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1055\/s-0038-1649724","article-title":"Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage","volume":"70","author":"Journet AM","year":"1993","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80542-5"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2003.00435.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01682.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01682.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:38:01Z","timestamp":1697189881000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01682.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01682.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01682.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,3]]}}}